Article
Detection of false positive mutations in BRCA gene by next generation sequencing.
Familial cancer - 1 Jul 2017
Suryavanshi Moushumi, Kumar Dushyant, Panigrahi Manoj Kumar, Chowdhary Meenakshi, Mehta Anurag
Abstract excerpt
BRCA1 and BRCA2 genes are implicated in 20-25% of hereditary breast and ovarian cancers. New age sequencing platforms have revolutionized massively parallel sequencing in clinical practice by providing cost effective, rapid, and sensitive sequencing. This study critically evaluates the false positives in multiplex panels and suggests the need for careful analysis. We employed multiplex PCR based BRCA1 and BRCA2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
